Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models
Authors:
- Razieh HassannejadRHRazieh Hassannejad
- Marjan MansourianMMMarjan Mansourian
- Hamidreza MaratebHamidreza Marateb
- Mohammad Reza MohebianMMMohammad Reza Mohebian
- Thomas Andrew GazianoTGThomas Andrew Gaziano
- Rodney T JacksonRJRodney T Jackson
- Emanuele Di AngelantonioEAEmanuele Di Angelantonio
- Nizal SarrafzadeganNSNizal Sarrafzadegan
Open Access
- 4 January 2021
- journal article
- research article
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 16 (1) , 58
Abstract
Developing simplified risk assessment model based on non-laboratory risk factors that could determine cardiovascular risk as accurately as laboratory-based one can be valuable, particularly in developing countries where there are limited resources. To develop a simplified non-laboratory cardiovascular disease risk assessment chart based on previously reported laboratory-based chart and evaluate internal and external validation, and recalibration of both risk models to assess the performance of risk scoring tools in other population. A 10-year non-laboratory-based risk prediction chart was developed for fatal and non-fatal CVD using Cox Proportional Hazard regression. Data from the Isfahan Cohort Study (ICS), a population-based study among 6504 adults aged ≥ 35 years, followed-up for at least ten years was used for the non-laboratory-based model derivation. Participants were followed up until the occurrence of CVD events. Tehran Lipid and Glucose Study (TLGS) data was used to evaluate the external validity of both non-laboratory and laboratory risk assessment models in other populations rather than one used in the model derivation. The discrimination and calibration analysis of the non-laboratory model showed the following values of Harrell’s C: 0.73 (95% CI 0.71–0.74), and Nam-D’Agostino χ2:11.01 (p = 0.27), respectively. The non-laboratory model was in agreement and classified high risk and low risk patients as accurately as the laboratory one. Both non-laboratory and laboratory risk prediction models showed good discrimination in the external validation, with Harrell’s C of 0.77 (95% CI 0.75–0.78) and 0.78 (95% CI 0.76–0.79), respectively. Our simplified risk assessment model based on non-laboratory risk factors could determine cardiovascular risk as accurately as laboratory-based one. This approach can provide simple risk assessment tool where laboratory testing is unavailable, inconvenient, and costly.Keywords
This publication has 30 references indexed in Scilit:
- The Isfahan cohort study: Rationale, methods and main findingsJournal of Human Hypertension, 2010
- Value and Limitations of Existing Scores for the Assessment of Cardiovascular RiskJACC, 2009
- Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohortThe Lancet, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort studyBMJ, 2007
- Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)Heart, 2006
- Cost-Effectiveness Analysis of Hypertension Guidelines in South AfricaCirculation, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and controlActa Cardiologica, 2003
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003